Semaglutide, a drug widely used for diabetes and weight management, is now being tested in major trials for its potential to slow early-stage Alzheimer’s disease.
A recent review of studies has highlighted the growing significance of inflammatory biomarkers in understanding the complexities of major depressive disorder (MDD).
A new meta-analysis has revealed that interventions targeting mood disorders can lead to significant reductions in inflammatory biomarkers in individuals with inflammatory bowel disease.
Stroke is the leading cause of disability worldwide and the second leading cause of death, but the right early intervention can prevent severe consequences.
Measuring markers of cellular metabolism has become an important approach to studying mental illnesses and developing new ways to diagnose, treat, and prevent them.
Extreme stressors like psychiatric disorders or childhood neglect and abuse can lead to a range of health problems later in life, including depression, anxiety, and cardiovascular disease.
An international team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer’s and Parkinson’s diseases.
Until recently, our understanding of Parkinson's disease has been quite limited, which has been apparent in the limited treatment options and management of this debilitating condition.